diseases. The formation of these crystals in vitro after disruption of human eosinophils, but not of other cell types, in hypotonic saline or detergent established the eosinophil as the unique cellular source of the crystalline protein. Charcot -yden crystals have now been found to express lysophospholipase activity (lysolecithin acylhydrolase, EC 3.1.1.5), and the solubilized Charcot-Leyden crystal protein presents a single stained protein band that is coincident with the lysophospholipase activity eluted from replicate gels on alkaline polyacrylamide gel electrophoresis. On sodium dodecyl sul ate/polyacrylamide gel electrophoresis, the solubilized Charcot-Leyden crystal protein migrates with a molecular weight of 17 ,400, which is comparable to that of eosinophil lysophospholipase purified chromatographically to homogeneity; further, on combination, the two proteins comigrate as a single staining band. Finally, the chromatographically purified eosinophil lysophospholipase in hypotonic buffer forms dipyramidal crystals morphologically identical to Charcot-Leyden crystals. The findings that chromatographically purified, homogeneous eosinophil lysophospholipase and Charcot-Leyden crystal protein express the same enzymatic activity, are of the same size and charge, and form crystals of identical morphology indicate that human eosinophil lysophospholipase is the constituent of Charcot-Leyden crystals.
Prominent blood or tissue accumulations of eosinophilic leukocytes occur in many allergic reactions and helminthic infections as well as in the course of some neoplastic, inflammatory, and immunodeficiency diseases (1). Charcot-Leyden crystals (CLC), which are characteristically long, slender, dipyramidal crystals, were initially described in the mid-nineteenth century (2, 3) and are hallmarks of eosinophil involvement in some tissue reactions. CLC may be prominent in sputum of patients with asthma (3), pulmonary ascariasis (4), and tropical eosinophilia (5) , in the feces of patients with amebic, Trichuris, or ulcerative colitis (6) , and in tissues containing eosinophilic granulomas of bone (7) and granulomas associated with tissue-invading helminths (8) .
Disruption of eosinophils either by detergents (9) or by homogenization and suspension in hypotonic saline (5) allows for the formation of CLC in vitro. Similar disruption of other classes of leukocytes or of eosinophils derived from nonprimate mammalian species fails to result in CLC formation (10) . Thus, eosinophils, specifically those from primate species, have been established as the unique cellular source of this crystalline material (11) . Human CLC are composed of a single protein, which differs from the major basic protein, the predominant protein in the large granule of the eosinophil (12) . The intracellular source of the eosinophil CLC protein remains uncertain, although nuclear (9), granular (10) , and cytoplasmic (12) origins have been proposed. Further, no biochemical activity or biologic function has been established for the protein composing the crystals (11) . The findings that chromatographically purified, homogeneous eosinophil lysophospholipase (lysolecithin acylhydrolase, EC 3.1.1.5) and CLC protein express a common enzymatic activity, exhibit the same physicochemical characteristics of size and charge, and form crystals of identical morphology establish human eosinophil lysophospholipase as the constituent of CLC. Blood from normal donors provided neutrophils, mononuclear cells, platelets, and erythrocytes (13) , and donors with blood eosinophilias due to trichinosis, filariasis, drug allergies, and a hypereosinophilic syndrome provided granulocytes enriched in eosinophils (14) . Eosinophils from a donor with hypereosinophilia (leukocyte count of 28,000-36,000/mm3 of blood with 87-94% eosinophils) were used without further purification as a source of protein for formation of CLC and for isolation of enzyme.
MATERIALS AND METHODS
Assay of Lysophospholipase. The cell preparations were disrupted by sonication and dialyzed against 0.1 M NaCl overnight before assay of cellular lysophospholipase. A 100 to 200-,1 portion of cell extract or chromatographic fraction was added to a reaction mixture with a final volume of 1 ml, conAbbreviation: CLC, Charcot-Leyden crystals. 7440 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (17) with the modifying addition of 2 mM dithiothreitol to the electrode buffer. Gels were electrophoresed at 2.5 mA per gel for 3 hr before use.
RESULTS
For the same numbers of disrupted human peripheral blood leukocytes, lysophospholipase activity in the eosinophil-enriched granulocytes was 8-fold greater than that in the neutrophil-enriched granulocytes and 3-fold greater than that of the mononuclear leukocytes (Fig. 1) . Relatively trivial activity was present in platelets and erythrocytes.
In a preliminary experiment, 200 Ml of pelleted CLC contained 184 units of lysophospholipase activity when assayed directly. To determine if this enzyme activity was a major component of the crystal, lyophilized CLC were solubilized in 0.1 M Tris-HCI, pH 7.5/2 mM EDTA, and 40-jg quantities of protein, as assessed by the Bio-Rad assay using human IgG as a reference standard, were subjected to alkaline disc gel electrophoresis in two replicate gels. In the gel stained with Coomassie brilliant blue, a single stained protein band was present. The parallel gel was sliced into 2-mm sections and each section was macerated in 500,ul of 0.1 M Tris-HCl, pH 7.5/2 mM EDTA/2 mM dithiothreitol and dialyzed overnight against the same buffer at 40C with 6000-8000 Mr cut-off dialysis membranes. Of the lysophospholipase activity recovered from eluted slices of this gel, 88% was in a 6-mm region coincident with the stained protein band (Fig. 2) .
Eosinophil lysophospholipase, purified to homogeneity as judged by presentation of a single stained protein band on alkaline disc gel electrophoresis and NaDodSO4/polyacrylamide gel electrophoresis of 40 ,ug each, was subjected to NaDodSO4/polyacrylamide gel electrophoresis in parallel and in concert with CLC protein. Each protein migrated with the same RF and in combination they comigrated to give a single band (Fig. 3) . The molecular weight of CLC (Fig. 4), using 10 ,g of CLC for each of six determinations, was 17,400 : 300 (SEM), which is the same as the molecular weight of human eosinophil lysophospholipase, 17 ,200 + 200 (SEM) (n = 9).
A solution of 900,g of purified eosinophil lysophospholipase in 500 Al of 0.1 M Tris-HCl, pH 7.5/2 mM EDTA/2 mM dithiothreitol, was made hypotonic by addition of 1 ml of 0.15% NaCl and concentrated at 40C to original volume by negative-pressure ultrafiltration on a 10,000 Mr collodion bag. Crystals with a morphology identical to that of CLC formed within minutes of concentration (Fig. 5) . Alkaline disc gel electrophoresis of solubilized CLC protein derived from human eosinophils. Protein was applied to parallel gels in 40-ag portions; one gel was stained with Coomassie brilliant blue and the other was sliced and eluted for assay of lysophospholipase activity. The anode was at the right and the dye front was marked by an ink stab.
DISCUSSION
The observation of prominent lysophospholipase activity associated with the eosinophil was made with rat leukocytes on the basis of the histochemical precipitation of (18) and the titration of (19) fatty acid liberated from the substrate lysolecithin. Human eosinophils manifest more lysophospholipase activity than other leukocytes in a sensitive and specific assay based on quantitating the release of radiolabeled fatty acid from [14C]palmitoyl lysophosphatidylcholine (14) . Human eosinophils express 8-fold more lysophospholipase activity than do neutrophils and 3fold more than mononuclear leukocytes (Fig.  1) . Thus, in the human, and possibly in rats (19) and mice (20) , the eosinophil is preferentially endowed with the enzymatic capability to deacylate lysophospholipids.
During the course of purifying lysophospholipase from the human eosinophil (14) , the similarity of physicochemical properties between this enzyme and the protein composing CLC suggested that the two might be related. CLC prepared from human eosinophils by ultrasonic disruption of the cells in hypotonic saline were found to express prominent lysophospholipase activity. Alkaline disc gel electrophoresis of CLC protein yielded a single band of Coomassie brilliant blue staining protein that was coincident with lysophospholipase activity recovered from a parallel gel (Fig. 2) adsorbed to the crystal. Moreover, on electrophoresis under dissociating conditions, after reduction and alkylation in the presence of NaDodSO4 detergent, CLC protein migrated as a single band with the same mobility as purified eosinophil lysophospholipase; indeed, the two proteins comigrated on a single gel (Fig. 3) . Additional confirmation that eosinophil lysophospholipase was the sole protein constituent of CLC was obtained by the demonstration that purified enzyme in hypotonic buffer formed dipyramidal crystals morphologically identical to CLC (Fig. 5) .
Chemical knowledge of CLC was limited until Gleich and his associates found CLC to consist of a 13,000 Mr acidic protein whose molecular weight and amino acid composition distinguished it from the 9300 Mr major basic protein, the principal constituent of eosinophil large granules (12, 21) . In the present study, molecular weights of the CLC protein and the purified lysophospholipase are similar, being 17,400 and 17,200, respectively. The greater molecular weight of CLC in the present study as compared to the molecular weights in the literature (12, 21) is not due to aberrant migration of eosinophil lysophospholipase, because analysis of the electrophoretic mobility on NaDodSO4/polyacrylamide gel electrophoresis performed at four different concentrations of acrylamide, as suggested by Ferguson (22) , gave the same result. The introduction of additional molecular weight markers, the a and chains of hemoglobin (about 15,000 Mr) (16) , confirmed the larger size of CLC and lysophospholipase. Some (5, 23) , but not all (24) , studies of CLC have found increased quantities of zinc associated with CLC, and the sulfhydryl dependence of lysophospholipase (18) allows for the possible binding of zinc ions by sulfhydryl groups of the cysteine residues (12, 23) . However, the purification of lysophospholipase in the presence of 2 mM EDTA and the ability of purified enzyme to form CLC in the presence of EDTA suggest that zinc is not an integral component of the crystals.
CLC persist in sputum, feces, and tissues of patients with eosinophil inflammatory processes and are resistant to proteolytic digestion by chymotrypsin, trypsin, and pepsin (25) . The retention of active lysophospholipase activity by CLC derived from human eosinophils raises the possibility that, even after the disintegration of eosinophils in inflammatory foci, the resulting CLC that are formed may represent an enzymatically active legacy that continues to function to degrade lysophospholipids. Because lysophospholipids are generated in inflammatory foci (26, 27) and may have a range of concentration-dependent cytotoxic and noncytolytic effects on diverse cells (28) (29) (30) (31) (32) , CLC formation and persistence in human tissues and fluids may represent more than a curious crystalline artifact and may have biological function.
